Skip Navigation

American Society of Hematology Recognizes Two OU Health Sciences Faculty

NEWS
James George and Jennifer Holter-Chakrabarty.
James George, M.D., (left) receives the Award for Leadership in Promoting Diversity from the American Society of Hematology. Jennifer Holter-Chakrabarty, M.D., (right) will serve a four-year term as councilor of the American Society of Hematology. Image by Kat Gebauer.

American Society of Hematology Recognizes Two OU Health Sciences Faculty


By

April Wilkerson
april-j-wilkerson@ouhsc.edu

Date

Dec. 18, 2024

OKLAHOMA CITY, OKLA. – Two University of Oklahoma Health Sciences faculty members were recognized by the American Society of Hematology (ASH) during its annual meeting Dec. 7-10.

James George, M.D., a George Lynn Cross Research Professor in the OU College of Medicine and Hudson College of Public Health, was honored with the ASH Award for Leadership in Promoting Diversity. During his career in academic medicine, George has helped to build a stronger hematology workforce by mentoring the next generation of hematologists.

Under his leadership as ASH president in 2005, the society collaborated with the Robert Wood Johnson Foundation’s Harold Amos Medical Faculty Development Program (AMFDP) to create ASH-funded AMFDP positions in hematology. Since the program’s inception, ASH has supported nearly 30 recipients, many of whom have risen to the ranks of senior faculty in their institutions.

George was also a strong supporter of the ASH Medical Student Award Program, which provides research support for medical students underrepresented in medicine to encourage them to pursue hematology. To date, the program has supported more than 300 research opportunities for medical students. Additionally, George co-developed and directed the ASH Clinical Research Training Institute, an inclusive yearlong program that offers broad education for clinicians on clinical research methods.

Jennifer Holter-Chakrabarty, M.D., a professor in the OU College of Medicine and hematologist-oncologist at OU Health Stephenson Cancer Center, was elected to serve a four-year term as an ASH councilor.

Holter-Chakrabarty’s research background is in leukemia, transplantation and imaging of marrow failure syndromes. An active ASH member since 2003, she is chair of the Committee on Government Affairs, co-chair of the Advocacy Leadership Institute, and served as an appointed member on the Guideline Oversight Committee.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university with campuses in Norman, Oklahoma City and Tulsa. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. In Oklahoma City, OU Health Sciences is one of the nation’s few academic health centers with seven health profession colleges located on the same campus. OU Health Sciences serves approximately 4,000 students in more than 70 undergraduate and graduate degree programs spanning Oklahoma City and Tulsa and is the leading research institution in Oklahoma. For more information about OU Health Sciences, visit www.ouhsc.edu.


Recent News

Campus & Community
April 27, 2026

175 OU Students Present Research at 38th Annual Undergraduate Research Day

The University of Oklahoma Honors College hosted its 38th annual Undergraduate Research Day on April 16 in the Thurman J. White Forum Building. Over 300 people attended, and 175 students presented their posters and projects to visitors, faculty members, judges and peers.


Impact
April 24, 2026

Where Practice Meets Leadership: OU and CCOSA Introduce Collaborative Ed.D.

The Collaborative Doctor of Education (Ed.D.) in Educational Leadership offers emerging leaders across Oklahoma’s PK–12 public education system a doctoral experience designed to be as relevant as it is rigorous.


Research
April 23, 2026

Genetic Study Finds New Pathways Involved in Cardiometabolic Disease

A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led by Dharambir Sanghera, Ph.D., of the University of Oklahoma, represents a step toward targeting the diseases more precisely.